leadf
logo-loader
viewArcher Materials Ltd

Archer Exploration registers provisional patent for biosensor ink

The company is the sole applicant of the patent and maintains 100% ownership of the patent and intellectual property.

Patent representation
Vital step in implementing Archer’s commercial plans

Archer Exploration Ltd (ASX:AXE) has registered a provisional patent with the Australian Patent Office, comprising intellectual property (IP) relating to graphene ink compositions, methods of synthesising the inks and the use of the inks for biomolecular sensing.

The registration of the patent is part of Archer’s strategy to commercially develop materials and technology in the key vertical of human health.

Background

Archer is engaged in a collaboration agreement with The University of Adelaide as part of the Australian Research Council Research Hub for Graphene Enabled Industry Transformation (ARC Graphene Hub).

The collaboration seeks to target high value, high growth markets servicing human health applications by developing and implementing graphene and carbon-based materials for use in complex biosensing devices.

Archer graphene-based ink derived from the Campoona deposit, printed as an interdigitated electrode pattern on a flexible polyimide film to be used as critical componentry in biosensor devices

The patent embodies Archer’s competitive advantages in ink formulation, printing, and use in targeting various diseases.

READ: Archer Exploration pursues quantum computing and resources projects

Archer chief executive officer Dr Mohammad Choucair said: “We are now capable of generating our own IP for commercial translation.

“The registration of the provisional patent is a vital step in implementing our commercial plans and in legally protecting our competitive advantages during development.

“It gives us up to 12 months to consider our commercial options prior to a full patent application.

“Importantly, we now have a timeline for commercialisation related to our maiden graphene-based biosensor technology in our human health vertical”.

Next steps

A provisional patent provides a 12-month period for Archer to consider filing a full patent application with the benefit of having established the earliest possible priority date.

Over the next 12 months Archer will access dedicated technical development resources and infrastructure support from The University of Adelaide as part of the ARC Graphene Hub collaboration, to perform the value-added claims and embodiment verification in support of a robust patent application.

Quick facts: Archer Materials Ltd

Price: 0.535 AUD

ASX:AXE
Market: ASX
Market Cap: $120.29 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Archer Materials making 'significant progress' towards qubit control

Archer Materials Ltd's (ASX:AXE) (OTCMKTS:ARRXF) (FRA:38A) CEO Dr Mohammad Choucair updates Proactive on progress they're making in advancing the current stage of development of its quantum computing chip. He says achieving qubit control would be a major validation of the commercial viability of...

1 week, 3 days ago

2 min read